sop_id,sop_number,title,category,version,effective_date,review_date,approved_by,summary,vector_note,created_at
SOP-001,QC-SOP-001,Dissolution Testing for Solid Oral Dosage Forms,quality,4.2,2024-06-01T00:00:00Z,2025-06-01T00:00:00Z,QA Director - Dr. Patricia Anderson,"Standard operating procedure for performing dissolution testing of tablets and capsules using USP Apparatus II (Paddle method). Includes equipment setup, calibration, sample preparation, testing parameters, and result documentation in compliance with FDA and USP requirements.",1536D vector field truncated - use OpenAI embedding,2024-06-01T08:00:00Z
SOP-002,MFG-SOP-015,Tablet Compression Process Control and Monitoring,manufacturing,3.1,2024-09-15T00:00:00Z,2025-09-15T00:00:00Z,Production Manager - James Mitchell,"Comprehensive procedure for tablet compression operations including equipment setup, punch and die installation, compression force optimization, weight variation monitoring, and in-process quality checks during production. Covers GMP requirements and troubleshooting common issues.",1536D vector field truncated - use OpenAI embedding,2024-09-15T09:30:00Z
SOP-003,REG-SOP-008,Adverse Event Reporting and Documentation,regulatory,2.5,2024-11-01T00:00:00Z,2025-11-01T00:00:00Z,Regulatory Affairs Manager - Dr. Amanda Foster,"Procedure for collecting, documenting, evaluating and reporting adverse events to regulatory authorities. Includes timelines for expedited reporting (7 and 15 days), causality assessment, MedDRA coding, and submission requirements for FDA MedWatch and EU EudraVigilance systems.",1536D vector field truncated - use OpenAI embedding,2024-11-01T10:00:00Z
SOP-004,QC-SOP-012,Out-of-Specification (OOS) Investigation Procedure,quality,3.3,2025-01-10T00:00:00Z,2026-01-10T00:00:00Z,QA Director - Dr. Patricia Anderson,"Systematic approach for investigating out-of-specification test results including initial assessment, laboratory investigation phase, manufacturing investigation phase, root cause analysis, corrective and preventive actions (CAPA), and final report documentation per FDA guidance.",1536D vector field truncated - use OpenAI embedding,2025-01-10T11:15:00Z
SOP-005,SAFE-SOP-003,Personal Protective Equipment (PPE) Requirements for Manufacturing Areas,safety,2.0,2024-08-01T00:00:00Z,2025-08-01T00:00:00Z,EHS Manager - Robert Chen,"Detailed requirements for personal protective equipment based on manufacturing area classification and material handling. Covers gowning procedures, glove selection, respiratory protection, eye protection, and proper donning/doffing sequences to maintain GMP compliance and worker safety.",1536D vector field truncated - use OpenAI embedding,2024-08-01T09:00:00Z
SOP-006,MFG-SOP-022,Cleaning and Sanitization of Manufacturing Equipment,manufacturing,2.8,2024-10-15T00:00:00Z,2025-10-15T00:00:00Z,Production Manager - James Mitchell,"Procedures for cleaning and sanitizing production equipment between batches including cleaning agent selection, cleaning validation, swab sampling, acceptance criteria, and documentation requirements. Prevents cross-contamination and ensures product quality.",1536D vector field truncated - use OpenAI embedding,2024-10-15T10:30:00Z
SOP-007,QC-SOP-018,HPLC Method for Assay Determination,quality,5.1,2024-07-20T00:00:00Z,2025-07-20T00:00:00Z,QA Director - Dr. Patricia Anderson,"High Performance Liquid Chromatography method for quantitative determination of active pharmaceutical ingredients. Includes system suitability requirements, sample preparation, standard curve preparation, calculation procedures, and method validation parameters per ICH guidelines.",1536D vector field truncated - use OpenAI embedding,2024-07-20T08:45:00Z
